# The Pharmacogenomics Journal

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/the-pharmacogenomics-journal/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1470-269X |
| ISSNs | 1470-269X,1473-1150 |
| OpenAlex ID | https://openalex.org/S141213272 |
| Publisher | Springer Nature |

## Journal papers

- [Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?](https://scholariq.org/papers/antipsychotic-drugs-activate-srebp-regulated-expression-of-lipid-biosynthetic/)
- [Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data](https://scholariq.org/papers/cost-effectiveness-of-cyp2c19-guided-antiplatelet-therapy-in-patients-with-acute/)
- [Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine](https://scholariq.org/papers/cost-effectiveness-of-hla-dqb1-hla-b-pharmacogenetic-guided-treatment-and-blood/)
- [Translational aspects of genetic factors in the prediction of drug response variability: a case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia](https://scholariq.org/papers/translational-aspects-of-genetic-factors-in-the-prediction-of-drug-response/)
- [Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults](https://scholariq.org/papers/economic-burden-of-adverse-drug-reactions-and-potential-for-pharmacogenomic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.